OmniComm Systems, Inc.  

(Public, OTCMKTS:OMCM)   Watch this stock  
Find more results for omcm
+0.005 (2.94%)
Apr 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.16 - 0.17
52 week 0.09 - 0.27
Open 0.16
Vol / Avg. 20,835.00/27,297.00
Mkt cap 15.77M
P/E     -
Div/yield     -
EPS -0.07
Shares 90.10M
Beta -1.22
Inst. own 4%

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin 49.82% -50.37%
Operating margin -0.95% 3.86%
EBITD margin - 7.78%
Return on average assets 246.17% -239.00%
Return on average equity - -
Employees 100 -
CDP Score - -


United States - Map
+1-954-4731254 (Phone)
+1-954-4731256 (Fax)

Website links


OmniComm Systems, Inc. is a Web-based electronic data capture (EDC) and eClinical (eClinical) software and services that streamline the clinical research process. The Company�s eClinical software and service offerings (eClinical Products or eClinical Solutions) include TrialMaster, TrialOne and eClinical Suite. The Company�s eClinical Products are designed to allow clinical trial sponsors and investigative sites to collect, validate, transmit and analyze clinical study data. The Company�s eClinical products are 21 CFR Part 11 compliant solutions and are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. The Company also provides business process consulting services that focus on integrating EDC and an array of eClinical Solutions and processes into the clinical trial process.

Officers and directors

Randall G. Smith Chairman of the Board, Chief Technical Officer
Age: 55
Stephen E. Johnson President
Age: 61
Cornelis F. Wit Chief Executive Officer, Director
Age: 62
Thomas E. Vickers Chief Financial Officer
Age: 49
Robert C. Schweitzer Director
Age: 67
Guus van Kesteren Independent Director
Age: 72